The KinematX Midcarpal Total Wrist Arthroplasty Registry
NCT ID: NCT05719935
Last Updated: 2023-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2021-04-26
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* What is the range of motion (flexion, extension, radial, ulnar, grip and pinch strength) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.
* What are the patient reported outcomes (PROMIS, PRWE, HSS wrist expectations) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.
* How do range of motion and patient reported outcomes change over the 10 years after total wrist replacement surgery?
Participants will be followed according to standard of care and preoperative and post-operative information for up to 10 years after surgery will be collected and entered into an electronic data base. Patients are eligible to enroll into the registry before or after they have had their wrist replacement surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Custom Orthosis Post Carpometacarpal (CMC) Arthroplasty
NCT05307510
Evaluation of a Conservative Treatment by Nocturnal Wrist Orthosis in the Non-surgical Management of Carpal Tunnel Syndrome (AMYLYONCARP)
NCT05483218
Outcomes of Treatment for Trapeziometacarpal Osteoarthritis
NCT01724853
Non-surgical Intervention for Carpal Tunnel Syndrome
NCT03360344
Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy
NCT03558204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
KinematX patients
Patients undergoing total wrist replacement with the KinematX implant.
KinematX total wrist arthroplasty system
The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KinematX total wrist arthroplasty system
The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* osteoarthritis or post-traumatic arthritis
* scapholunate advanced collapse (SLAC/SNAC wrist),
* inflammatory arthritis (rheumatoid, psoriatic, other),
* crystalline advanced collapse (SCAC),
* STT advanced collapse (STTAC),
* ulnar translocation,
* KienbÓ§ck disease,
* radial malunion
Exclusion Criteria
* \>85 years of age
* Prisoners
* Children
* Pregnant women
* Contraindications to receiving the KinematX:
* Local, distant or systematic acute or chronic soft tissue or bony infection
* Physiologically or psychologically compromised patient
* Active wrist synovitis or severe carpal bone erosion
* Suspected or documented metal allergy or intolerance
* Insufficient extensor tendons
* Inadequate skin, bone, neural or vascular status
* Severe carpal bone malalignment, displacement, absorption, neoplastic, or carpal bone pathology
* Sepsis
* Osteomyelitis
* Uncontrolled/untreated osteoporosis or metabolic bone disease
* Metabolic or endocrinologic bone disorders
* Osteomalacia
* Distant foci of infections which may spread to the implant site
* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Extremity Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian Smekal
Role: STUDY_DIRECTOR
Extremity Medical
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University
Loma Linda, California, United States
Florida Orthopaedic Institute
Tampa, Florida, United States
Franciscan Health
Indianapolis, Indiana, United States
Hospital for Special Surgery
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
112020-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.